methylprednisolone + heparin + antibiotics

**methylprednisolone + heparin + antibiotics** is a combination therapy comprised of three pharmacological classes: - **methylprednisolone**: a synthetic glucocorticoid corticosteroid used for its potent anti-inflammatory and immunosuppressive effects via glucocorticoid receptor-mediated transcription regulation. - **heparin**: an anticoagulant (unfractionated or low molecular weight) primarily used for the prevention and treatment of thromboembolic disorders, working through enhancement of antithrombin III activity and inhibition of thrombin and factor Xa. - **antibiotics**: a broad class of agents that inhibit or kill bacteria, with mechanisms and spectra depending on the specific antimicrobial(s) chosen. This combination is often used in critically ill patients, such as those with severe pneumonia (including COVID-19) or at high risk for both inflammation and thrombosis, and presumed or confirmed bacterial infection. Each agent targets a different component of the disease process: inflammation (methylprednisolone), hypercoagulability (heparin), and microbial infection (antibiotics)[1][4][6].